EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY-NC 4.0

Ventricular arrhythmias in arrhythmic mitral valve syndrome—a prospective continuous long-term cardiac monitoring study

Eivind W Aabel iD, Monica Chivulescu, Øyvind H Lie iD, Einar Hopp iD, Erik Gjertsen iD, Margareth Ribe iD, Thomas M Helle-Valle, Thor Edvardsen iD, Finn Hegbom, Lars A Dejgaard iD, Kristina H Haugaa iD

EP Europace · 2023

DOI: 10.1093/europace/euac182 ↗

Kurz gefasst

Kommentar in der Zeitschrift EP Europace, 2023. Verfasst von Eivind W Aabel und 10 weiteren Autor:innen. Beteiligte Einrichtung: ProCardio Center for Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet, PO Box 4950 Nydalen, 0424 Oslo, Norway. Hauptthemen laut MEDLINE: Tachycardia, Ventricular, Ventricular Premature Complexes, Defibrillators, Implantable. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Norwegian Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Arrhythmic mitral valve syndrome is linked to life-threatening ventricular arrhythmias. The incidence, morphology and methods for risk stratification are not well known. This prospective study aimed to describe the incidence and the morphology of ventricular arrhythmia and propose risk stratification in patients with arrhythmic mitral valve syndrome.

Methods

Arrhythmic mitral valve syndrome patients were monitored for ventricular tachyarrhythmias by implantable loop recorders (ILR) and secondary preventive implantable cardioverter-defibrillators (ICD). Severe ventricular arrhythmias included ventricular fibrillation, appropriate or aborted ICD therapy, sustained ventricular tachycardia and non-sustained ventricular tachycardia with symptoms of hemodynamic instability.

Results

During 3.1 years of follow-up, severe ventricular arrhythmia was recorded in seven (12%) of 60 patients implanted with ILR [first event incidence rate 4% per person-year, 95% confidence interval (CI) 2–9] and in four (20%) of 20 patients with ICD (re-event incidence rate 8% per person-year, 95% CI 3–21). In the ILR group, severe ventricular arrhythmia was associated with frequent premature ventricular complexes, more non-sustained ventricular tachycardias, greater left ventricular diameter and greater posterolateral mitral annular disjunction distance (all P < 0.02).

Conclusions

The yearly incidence of ventricular arrhythmia was high in arrhythmic mitral valve syndrome patients without previous severe arrhythmias using continuous heart rhythm monitoring. The incidence was even higher in patients with secondary preventive ICD. Frequent premature ventricular complexes, non-sustained ventricular tachycardias, greater left ventricular diameter and greater posterolateral mitral annular disjunction distance were predictors of first severe arrhythmic event.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tachycardia, VentricularVentricular Premature ComplexesDefibrillators, ImplantableHumansMitral ValveProspective StudiesVentricular FibrillationSyndromeDeath, Sudden, Cardiac

Stichwörter der Autor:innen

CardiomyopathyImplantable loop recorderMitral annular disjunctionMitral valve prolapseSudden cardiac deathVentricular tachycardia

Autor:innen und Institutionen

  • ProCardio Center for Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet, PO Box 4950 Nydalen, 0424 Oslo, Norway.
  • Institute of Clinical Medicine, University of Oslo, PO Box 1171 Blindern, 0318 Oslo, Norway.
  • Division of Radiology and Nuclear Medicine and The Intervention Centre, Oslo University Hospital, Rikshospitalet, PO Box 4950 Nydalen, 0424 Oslo, Norway.
  • Department of Medicine, Drammen Hospital, Vestre Viken Hospital Trust, Vestre Viken HF, PO Box 800, 3004 Drammen, Norway.
  • Department of Medicine, Department of Cardiology, Huddinge, Karolinska Institutet, Karolinska University Hospital, 171 77 Stockholm, Sweden.

ORCID-Profile: Eivind W Aabel, Øyvind H Lie, Einar Hopp, Erik Gjertsen, Margareth Ribe, Thor Edvardsen, Lars A Dejgaard, Kristina H Haugaa

Förderung

  • Norwegian Research Council

Zitieren

APA

Aabel, E. W., Chivulescu, M., Lie, Ø. H., Hopp, E., Gjertsen, E., Ribe, M., Helle-Valle, T. M., Edvardsen, T., Hegbom, F., Dejgaard, L. A., & Haugaa, K. H. (2023). Ventricular arrhythmias in arrhythmic mitral valve syndrome—a prospective continuous long-term cardiac monitoring study. EP Europace. https://doi.org/10.1093/europace/euac182

Vancouver

Aabel EW, Chivulescu M, Lie ØH, Hopp E, Gjertsen E, Ribe M, et al. Ventricular arrhythmias in arrhythmic mitral valve syndrome—a prospective continuous long-term cardiac monitoring study. EP Europace. 2023. doi:10.1093/europace/euac182

BibTeX
@article{Aabel2023,
  author = {Aabel, Eivind W and Chivulescu, Monica and Lie, Øyvind H and Hopp, Einar and Gjertsen, Erik and Ribe, Margareth and Helle-Valle, Thomas M and Edvardsen, Thor and Hegbom, Finn and Dejgaard, Lars A and Haugaa, Kristina H},
  title = {Ventricular arrhythmias in arrhythmic mitral valve syndrome—a prospective continuous long-term cardiac monitoring study},
  journal = {EP Europace},
  year = {2023},
  doi = {10.1093/europace/euac182}
}
Kostenlos starten →